Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration

[1]  A. Zaravinos.  The Regulatory Role of MicroRNAs in EMT and Cancer , 2015, Journal of oncology.

[2]  Hongchuan Jin,et al.  MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges , 2015, BioMed research international.

[3]  Xuhui Zhou,et al.  Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway. , 2014, Oncology reports.

[4]  Xiang Hu,et al.  MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis , 2013, Oncology letters.

[5]  Xiaofeng Li,et al.  microRNA-372 maintains oncogene characteristics by targeting TNFAIP1 and affects NFκB signaling in human gastric carcinoma cells. , 2013, International journal of oncology.

[6]  William P Schiemann,et al.  TGF-β upregulates miR-181a expression to promote breast cancer metastasis. , 2013, The Journal of clinical investigation.

[7]  Lijuan Guo,et al.  Decreased serum miR-181a is a potential new tool for breast cancer screening. , 2012, International journal of molecular medicine.

[8]  G. Capurso,et al.  Molecular pathology and genetics of pancreatic endocrine tumours. , 2012, Journal of molecular endocrinology.

[9]  Jian-yong Li,et al.  miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. , 2012, Carcinogenesis.

[10]  Pei Wang,et al.  miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[11]  Yue Yu,et al.  Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Yu-Jin Jung,et al.  RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells , 2009, International journal of cancer.

[13]  F. Balkwill.  Tumour necrosis factor and cancer , 2009, Nature Reviews Cancer.

[14]  Junxia Zhang,et al.  hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells , 2008, Brain Research.

[15]  B. Aggarwal,et al.  TNF: a master switch for inflammation to cancer. , 2008, Frontiers in bioscience : a journal and virtual library.

[16]  C. Croce,et al.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. , 2007, JAMA.

[17]  Thomas D. Schmittgen,et al.  Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.

[18]  R. Pillai.  MicroRNA function: multiple mechanisms for a tiny RNA? , 2005, RNA.

[19]  M. Safioleas,et al.  Pancreatic cancer today. , 2004, Hepato-gastroenterology.

[20]  R. Williamson,et al.  Pancreatic cancer: the greatest oncological challenge , 1988, British medical journal.

[21]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[22]  E. Barillot,et al.  Integrated Systems and Technologies Cancer Research miR-181 a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death , 2010 .

[23]  J. Michálek,et al.  MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients. , 2010, Neoplasma.